Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CorMedix Inc.

www.cormedix.com

Latest From CorMedix Inc.

Variety Of Impacts COVID-19 Poses For Biopharma Reflected In Earnings Calls

Several firms reporting quarterly earnings this week discussed how the outbreak is affecting supply chains, drug launches and clinical trials.

Coronavirus COVID-19 Sales & Earnings

Cormedix Leads Limited Pipeline For US FDA’s LPAD Pathway

Cormedix prepares NDA submission for Neutrolin for prevention of catheter-related blood stream infections, aiming to become the third approval under the US FDA’s Limited Population Pathway.

Infectious Diseases Review Pathway

US FDA's Antimicrobial Head Ed Cox Leaves For Regeneron; Agency Needs New LPAD Champion

Long-time deputy John Farley becomes acting director of the Office of Antimicrobial Products. Cox, who served as the director of the office for more than a decade, joins Regeneron to serve as vice president of regulatory affairs.

FDA Leadership

Antibiotic Stakeholders Discuss Ethics Of Testing Limited Population Drugs In Broader Populations

The US FDA's LPAD draft guidance suggests that clinical trials for potential limited population antibacterials would enroll broader patient populations. But is that an ethical approach?

Clinical Trials Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Infectious & Viral Diseases
  • Inflammation
  • Renal System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CorMedix Inc.
  • Senior Management
  • Khoso Baluch, CEO
    Robert W Cook, CFO
    Anthony E Pfaffle, MD, CSO
    Judith R Abrams, MD, CMO
    John Ortiz, VP, RA and QA
  • Contact Info
  • CorMedix Inc.
    Phone: (908) 517-9500
    1430 U.S. Highway 205
    Suite 200
    Bedminster, NJ 07921
    USA
UsernamePublicRestriction

Register